Tech Company Financing Transactions
Aeolus Pharmaceuticals Funding Round
Aeolus Pharmaceuticals, based in Mission Viejo, received $125 thousand in investment from private investors.
Transaction Overview
Company Name
Announced On
11/4/2008
Transaction Type
Venture Equity
Amount
$125,000
Round
Series D
Investors
Proceeds Purpose
The Company expects to use the net proceeds of $120,000 that it raised today from this financing to advance the development of AEOL 10150 and for general administrative expenses and working capital.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
26361 Crown Valley Pkwy. 150
Mission Viejo, CA 92691
USA
Mission Viejo, CA 92691
USA
Phone
Website
Email Address
Not Recorded
Overview
Aeolous Pharmaceuticals (OTC BB: AOLS) is a biopharmaceutical company that is developing a new class of catalytic antioxidant compunds, referred to as manganoporphyrins, for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John McManus
Chief Financial Officer
David Cavalier
Chief Scientific Officer
Brian Day
VP - Operations
Christopher Stanley
Browse more venture capital transactions:
Prev: 11/4/2008: Gnip venture capital transaction
Next: 11/4/2008: Open-Xchange venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs